BPC-157 / TB-500
Price range: $449.00 through $699.00
Tirzepatide
Price range: $399.00 through $589.00
Sold out
Description
Sermorelin was once FDA-approved under the brand Geref®, but the commercial product was discontinued for business reasons and not for safety concerns.
Today, Sermorelin is available only as a compounded medication supporting personalized peptide-based wellness strategies and is prepared for individual patients under clinician oversight.
Clients choose Sermorelin when their provider recommends a customized peptide option within a structured monitoring plan.
Additional information
| Weight | 0.065 lbs |
|---|---|
| Package | One-month supply, Two-months supply |
Customer Reviews
Related product
Reviews
Clear filtersThere are no reviews yet.